A nurse is caring for a client who has just begun therapy with alprazolam to treat anxiety. The nurse should monitor the client for which of the following adverse effects of this medication?
Hearing loss
Insomnia
Bradycardia
Hypertension
The Correct Answer is B
A. Hearing loss: Alprazolam, a benzodiazepine medication, is not typically associated with hearing loss. Adverse effects related to hearing are not commonly reported with the use of alprazolam.
B. Insomnia: Insomnia, or difficulty falling or staying asleep, is a potential adverse effect of alprazolam. While benzodiazepines like alprazolam are central nervous system depressants and can cause drowsiness, paradoxical reactions such as insomnia may occur in some individuals.
C. Bradycardia: Alprazolam is not known to cause bradycardia. Instead, it may cause mild tachycardia or irregular heart rhythms as potential cardiovascular side effects.
D. Hypertension: Alprazolam is more likely to cause hypotension (low blood pressure) rather than hypertension. Hypotension is a potential adverse effect due to its central nervous system depressant effects, which can lead to relaxation of blood vessels and decreased blood pressure.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
A. A pretreatment electroencephalogram (EEG) is not typically required before starting valproate therapy. EEGs may be used in the diagnosis and management of seizure disorders, but they are not a standard part of valproate therapy initiation.
B. High serum sodium levels are not associated with toxic levels of valproate. Instead, valproate can cause hyperammonemia, especially in individuals with urea cycle disorders.
C. Thyroid function tests are not typically required specifically for valproate therapy. However, valproate may interfere with thyroid hormone levels, so thyroid function tests might be ordered if there are symptoms of thyroid dysfunction.
D. Monitoring liver function tests is essential when taking valproate because the medication can cause hepatotoxicity. Clients should have baseline liver function tests before starting valproate, followed by regular monitoring throughout treatment. If liver function test results indicate liver damage, the healthcare provider may adjust the dosage or discontinue the medication. Therefore, this is the correct instruction to provide to the client starting valproate therapy.
Correct Answer is ["75"]
Explanation
To calculate the infusion rate in mL/hr for total parenteral nutrition (TPN) we divide the total volume by the total infusion time.
Given: Total volume of TPN = 1800 mL Total infusion time = 24 hours
Infusion rate (mL/hr) = Total volume / Total infusion time
Substituting the given values: Infusion rate = 1800 mL / 24 hr ≈ 75 mL/hr
Rounded to the nearest whole number, the nurse should set the IV pump to deliver approximately 75 mL/hr of TPN.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
